載入...
Validation and clinical utility of prostate cancer biomarkers
To improve future drug development and patient management for patients with castration-resistant prostate cancer (CRPC), surrogate biomarkers that are linked to relevant outcomes are urgently needed. A biomarker must be measurable, reproducible, linked to relevant clinical outcomes, and demonstrate...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3790270/ https://ncbi.nlm.nih.gov/pubmed/23459624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.30 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|